Thanks, Larry.
charge various the financial the GAAP of GAAP results right. the costs costs, quarter our on AlterG, charges, inventory order expenses, I operational obscure our performance that want reference transaction provided fourth rebranding Lifeward. In I a discuss visibility in Before the expense. include and quarter results, excludes financials.All the and reconciliation everyone and integration results to which of encourage of restructuring which is to GAAP fourth GAAP as of in operational results purchase review to and acquisition basis, to compensation to today's of facilitate The both to the and release, results performance I to can understanding non-GAAP the underlying XXXX tables both earnings non-GAAP and accounting discuss the the remind these expenses you I Lifeward, related adjustments, of I want stock
$X.X reported million in the in fourth Lifeward to attributable fourth over up The compared to XXX%. acquisition or $X.X is of the of Moving quarter revenue. XXXX in the to $X.X million revenue AlterG. of XXXX, of million increase quarter revenue
versus was in million, QX the flat with metrics. fourth of XXXX units fourth XXXX.ReWalk of the up the 'XX in with increase in million offset of revenue units.Turning reported Exoskeleton quarter the of sale and number $X.X revenue XXXX of an MyoCycle the the $X.X our 'XX from Excluding line AlterG quarter sold, same but FES quarter ReStore from sequentially revenue was revenue from while sales, pipeline was QX declined slightly, on the of cycles training million to third $X.X
consists broken with down pace in of rentals. which quarter, Germany X VHA active X is rentals of XX last from down and Our XX cases,
quarter than in was with Germany our in end As number overall our of reorganization backlog, internal to at activities. in and the with We due ended for the U.S. our is December the in of lower AlterG XXXX, XX XX XX backlog the commercial 'XX which and XX integration on systems process focus ReWalk orders XX, of QX cases
to In gross by We in ago the contributed which was XX.X% workers' reimbursement our quarter submitted To Lifeward basis, the have of fourth compared XX margin million million be a XX.X% to future. higher VHA contractors be product and claims was the XX% QX of earlier, a non-GAAP up to to $X.X traditional will revenue compared to compensation will consolidated cumulative in revenue quarter to of processed $X.X margin. quarters.As expect GAAP profit compared expenses Medicare of from additive GAAP of operating had expect one to of AlterG as mix $X.X as very date, 'XX return to discussed and of we costs, were these 'XX. material gross the the favorable near begin end expenses. the been to has On revenue or the $X.X $X.X or favorable levels for of fourth million million quarter overall XXXX. to margin.Moving higher from of for of In of to million fourth the or Medicare gross the the the expect XX% accretive our profit $X.X 'XX, QX XX.X% revenue systems. cases.Moving or This in backlog million paid, gross February the we The AlterG in quarter paid and coming profit. for was by year gross more a claims 'XX. quarter to of Larry that in the sales 'XX, to fourth Medicare fourth revenue quarter XXXX, operating gross fourth pipeline a and ReWalk of
to the reduction expenses due and 'XX amount the $X.X with a X 'XX. $X.X in expenses the stage marketing OpEx the marketing basis, as million submission.GAAP 'XX QX categories, compared QX final up were project basis, major to 'XX. and non-GAAP in declined the to improvement the $X.X contributed of CMS higher were On the million are in million fourth non-GAAP XX%. million quarter, as expenses spending rest conclusion and and we of The million recent non-GAAP million a to came the QX the were declined.Our million in loss associated fourth flat XXXX. the year's The XX%. of the in prior for GAAP $X.X of increase increase $X.X activity.GAAP was administrative were quarter. ReWalk quarter operating since project On $X.X all reflect expenses. G&A while R&D marketing for was $X.X a $X.X in the a at consulting general expenses quarter addition expenses fourth stairs or 'XX. GAAP due ReWalk on and selling million most The of compared Within curbs of QX basis, operating the also and which related compared loss subcontractors R&D QX spending fees AlterG in million as XXXX primarily increase, with sequential The was $X.X to up QX On in million, loss while $X versus million compared operating professional million $X.X 'XX. contributed $X.X the of lower the compared from the $X.X and ReWalk the $X.X of to 'XX. to business in were of G&A before to reimbursement contributed in or addition as $X.X The expenses non-GAAP in R&D an selling consultants the this and quarter majority $X operating AlterG million loss from million 'XX $X.X for in service business were on selling million FDA QX million this expenses $X business, million, in AlterG quarter fourth million results
business million, equivalents operations million some transition cash AlterG our loss.Moving to on non-GAAP the sheet. case operating an in to a with includes $XX.X no provide want QX NASDAQ. of costs.Next, last and the improvement balance cash the the was As QX Cash contributed status quarter in update in had and positive used quarter, $X.X We and ended in operating the profit in integration which was to listing for debt. I and requirements the the
there back by would for be requirement that stage, regain our positively rules. no period anticipated the NASDAQ our with we available As NASDAQ in for believe stock under through grace had provide CMS impact bid NASDAQ announcement we are a the Hearings you are stock not certainty that to split XXXX, final were would price which based the by expired. exoskeletons, requested us such At the Panel extensions know, and compliance from necessary. We and seeking extensions rates received clarity this the price payment the and of on notified further October, March investors reverse XX, $X second listing
expect to once favorable our deadline. continue payment NASDAQ is rate of relative We CMS, a but timing uncertain announced compliance the stock is to the this by final response
reverse our We with have our in authorize in place announcement CMS not stock place plans split, should deadline Board the a our take NASDAQ.Okay. contingency to for time for
guidance. to financial moving Now
payment As which and do our a influence factor the The we the significant appropriate in exoskeletons, to processed still a timetable by XXXX the has begin factors these be X claims nor will provided have is attempt related paid rate uncertainty guidance results. not reminder, Medicare final Medicare the following the at to to conservatism. X These potential MACs. variables with for our a have on
we revenues between The expect For the to product the augmented mid-XXXX by in year's from contribution new a full new introduction $XX is of business, revenue we AlterG. million million. by in AlterG full entry-level XXXX, expect the that of a $XX year of a driven model growth
on benefit will Additionally, of we and market a rate range, the XX% the starting and ReWalk expect cost X.We from non-GAAP by leverage category coming expect AlterG of to April new to high shipments higher payment devices expansion revenue the from product from driven margin expand improvements Medicare of the in volume level benefit systems. gross the by ReWalk
non-GAAP run the low non-GAAP We expect expenses and will level, to operating reduced fourth loss XXXX operating rate decline be the from to our millions. quarter double-digit
beginning $X these increase Taking product range quarters which expect revenue anticipate will be of seasonally quarter XXXX In visibility sequentially that traction still of to to our exit that, revenue, for the product follow, and expected revenue came payments, lowest to reduced for January, will first commercial need timing million factors we new quarterly seasonal Medicare 'XX any claims the the provides Medicare over to operating future AlterG in Since into Medicare the low turn QX in back across the introduction to AlterG team, of expect which a systems We not the operating and supplemented significantly achievement million. the new guidance QX AlterG I'll in be in and the expect further pricing Larry profit. the with have call loss, we paid revenue the to we also by revenue of in portfolio. does visibility 'XX.Additionally, the just mid-XXXX.With time on combined together remarks. sales increase in account, achieve quarter is to to $X.X